Sales Forces – PharmaLive

Agenda 2022: The new normal

Agenda, Coronavirus Disease (COVID-19) Pandemic, Coronavirus Disease 2019 (COVID-19), Customer Experience, Digital, FDA/Regulatory, February 2022, Health Technology, Issue Archives, Marketing & Advertising, Med Ad News, Pharma, Rare Diseases, Sales Forces, Special Features, Virtual

Remember back in March and April and May of 2020, when people prefaced their plans for the future with, “When we get back to normal”? We never did, and we never will. The COVID experience has forever changed how all of us view the world, how we interact with each other … and, of course, how we interact with healthcare brands and what we expect from them. In seeking out insights from pharma’s wise heads for Med Ad News’ annual Agenda report, we tried to maneuver around COVID at least a little, to see what else was going on in the industry. But the plain fact is that we couldn’t, not really.

February 13, 2022/by Joshua Slatko

Anticipating a Permanent Shift to Virtual, Pfizer will Reduce Sales Reps

Business, Coronavirus Disease (COVID-19) Pandemic, Job Cuts, Pfizer, Sales Forces, Sales Reps

Sparked by more than two years of virtual meetings due to the COVID-19 pandemic, Pfizer is cutting the company’s sales staff as more and more physicians’ offices and healthcare facilities prefer fewer face-to-face interactions with vendors. That preference for a virtual experience is expected to remain even after the pandemic wanes.

January 12, 2022/by BioSpace

Greater Than One’s Christa Toole analyzes how healthcare marketers are adjusting to the current health crisis in a variety of ways.

June 8, 2020/by Administrator

Amarin Plans to Double Size of Sales Force to 800

"Bad" LDL Cholesterol, Business, Cardiovascular Risk, FDA, Fish Oil, Sales Forces, Sales Guidance, Supplemental New Drug Application (sNDA), Triglycerides

Amarin Corp. provided an update, noting that the company is increasing revenue guidance for 2019 and is planning to expand the sales force for Vascepa due to faster-than-expected growth.

July 2, 2019/by BioSpace

Purdue Pharma Cuts More Than Half of U.S. Sales Staff

Business, Crisis, Department of Health and Human Services (HHS), Opioids, Sales Forces, Sales Reps, U.S. Centers for Disease Control and Prevention

OxyContin maker Purdue Pharma LP is slashing its sales force in half as the company changes the marketing strategy for the chronic pain pill OxyContin amid the opioid abuse crisis.

February 13, 2018/by Reuters Health

OxyContin maker stops promoting opioids

Business, Crisis, Doctors, Donald Trump, Lawsuits, Opioids, Painkillers, Sales Forces, U.S. Centers for Disease Control and Prevention, U.S. Justice Department

OxyContin maker Purdue Pharma LP has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers.

February 10, 2018/by Reuters Health

Special Feature: Interesting times for pharma sales reps

Business, Digital, Donald Trump, February 2017, Healthcare Physicians, Healthcare Providers, Issue Archives, Marketing & Advertising, Patients, Sales & Marketing, Sales Forces, Sales Reps, Technology

Despite the general anxiety over the impact of President Trump’s policies, when it comes to pharmaceutical sales forces, little of what he does will actually affect pharma sales-force strategies. The trends that are continuing to play out are declining rep access, the size of pharma sales forces, and the struggle with the concept of key account management, as well as trying to figure out how reps should be compensated.

February 14, 2017/by Christiane Truelove

Valeant’s $10 Billion Salix Deal With Takeda Falls Apart

Analysts, Business, Deals, Diarrhea, Gastrointestinal, Health, Healthcare Physicians, M&A, Sales Forces, Stocks

A deal for Japan’s Takeda to acquire Laval, Quebec-based Valeant’s Salix gastrointestinal drugs business has reportedly fallen through.

December 1, 2016/by BioSpace

3 Facts Life Sciences Companies Need to Know About Medical Claims

Business, Data, Data Intelligence, Doctors, Electronic Health Records, Life Sciences, Medical Devices, Pharma, Prescriptions, Rheumatoid Arthritis, Sales Forces, Sales Reps, Social media, Technology

There are 3 key facts life sciences companies need to know about real-time or near real-time medical claims data to support timely business decision-making.

September 27, 2016/by Administrator

U.S. approves Aralez pill for heart patients

Approvals, Aspirin, FDA, FDA/Regulatory, Forecasts, Gastric Ulcers, Gastrointestinal, Health, Sales Forces, Shares

The U.S. FDA approved a pill that combines aspirin and the acid-fighting drug omeprazole to guard against gastric ulcers in patients who require daily aspirin.

September 15, 2016/by Reuters Health